Please enable Javascript on your browser for a better experience.
The Apolipoprotein B (ApoB) Test measures ApoB, the main protein in LDL and VLDL cholesterol, to assess cardiovascular risk. Elevated ApoB is linked to atherosclerosis, coronary artery disease, heart attack, and stroke. Low levels may reflect liver disease or malnutrition. Doctors often order this test with lipid panels or Apo A1 to calculate the ApoB/A1 ratio, providing a more accurate picture of cholesterol balance, cardiovascular health, and risk for heart disease.
The Cardio IQ™ Apolipoprotein B Test measures ApoB, the main protein in LDL and other atherogenic lipoproteins. Elevated ApoB levels are linked to higher cardiovascular risk. This test provides a more precise assessment of heart disease risk than standard cholesterol tests and helps guide treatment decisions.
The Apolipoprotein A1 and B Test measures Apo A1, the main protein in HDL cholesterol, and Apo B, the primary protein in LDL and VLDL cholesterol. Together, these markers and the ApoB/A1 ratio provide a clearer picture of cardiovascular risk than standard lipid panels. High ApoB or low Apo A1 may signal heart disease, stroke, or atherosclerosis. Doctors use this test to evaluate cholesterol balance, monitor therapy, and guide prevention of cardiovascular conditions.
The Apolipoprotein A1 (Apo A1) Test measures levels of Apo A1, the main protein in HDL cholesterol, to assess heart and vascular health. Higher levels are linked to protective “good” cholesterol, while low levels may increase risk of heart disease, stroke, or metabolic disorders. Doctors use this test with lipid panels to evaluate cardiovascular risk, monitor therapy, and guide prevention strategies for cholesterol balance and heart health.
The Cardio IQ™ Apolipoprotein A1 Test measures ApoA1, the main protein in HDL cholesterol. Higher ApoA1 levels are generally linked to lower cardiovascular risk. This test helps evaluate heart health, lipid metabolism, and supports assessment of cardiovascular disease risk.
The Cardio IQ™ Apolipoprotein Evaluation Test measures both ApoA1, the main protein in HDL, and ApoB, the main protein in LDL and other atherogenic lipoproteins. The balance between these markers provides a detailed assessment of cardiovascular risk, lipid metabolism, and helps guide heart disease prevention and treatment.
The AALP Apolipoprotein C3 Test measures apolipoprotein C-III, a key regulator of triglyceride metabolism and lipoprotein clearance. Elevated ApoC-III levels are linked to impaired triglyceride breakdown, atherogenic remnant particles, and increased cardiometabolic risk. This advanced blood test provides deeper insight beyond standard lipid panels, helping identify hidden cardiovascular and metabolic risk and supporting more personalized lipid health assessment.
The Remnant & Particle Burden Panel evaluates advanced lipid, particle, and inflammatory markers to uncover hidden cardiovascular risk. By combining a comprehensive lipid panel with ApoB, ApoC-III, Direct LDL, hs-CRP, and Lipoprotein (a), this blood test assesses atherogenic particle number, remnant burden, inherited risk, and vascular inflammation beyond standard cholesterol testing.
Advanced Remnant & Particle Risk Panel
Advanced cardiovascular panel measuring lipoprotein particle size and number, ApoB, Lipoprotein (a), hs-CRP, homocysteine, TSH, and a full lipid profile. Designed to refine atherosclerosis and coronary heart disease risk assessment beyond standard cholesterol testing, this panel supports deeper evaluation of arterial health, inflammation, and metabolic influences.
The Omega-3 & Advanced Heart Risk Panel — Comprehensive delivers a deeper look at cardiovascular and metabolic health by combining advanced lipid markers, inflammation testing, glycemic assessment, and omega-3 status. Measuring ApoB, lipoprotein(a), lipid ratios, insulin, hemoglobin A1c, hs-CRP, and OmegaCheck, this panel provides an integrated view of heart disease risk and cardiometabolic balance.